MICROFOAM CHEMICAL ABLATION
DEAD

Serial Number

86531766

Owner

Provensis Limited

Attorney

Jonathan A. Hyman

Filing Date

Feb 11, 2015

Add to watchlist:

No watchlists yet
View on USPTO

MICROFOAM CHEMICAL ABLATION Trademark

Serial Number: 86531766

MICROFOAM CHEMICAL ABLATION is a trademark filed by Provensis Limited on February 11, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Provensis Limited (15 trademarks)

5 Fleet Place

Entity Type: 99

Trademark Details

Filing Date

February 11, 2015

Registration Date

Not Registered

Goods & Services

Education, namely, developing, arranging and conducting educational conferences, seminars, workshops and programs and providing courses of instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; provision of educational content namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; medical training; training in the use and operation of pharmaceutical products, pharmaceutical preparations; provision of educational classes and training in the field of pharmaceutical products, healthcare and medical diseases, disorders and related treatments; provision of educational classes and training in the field of health and medical information; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions, and training programs in the fields of healthcare, the use of pharmaceutical and medical devices, medical research, surgery, medical science, medicine and medical diseases, disorders and related treatments; Educational services, namely, providing non-downloadable webinars in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions and training in the field of health; educational services, namely, providing non-downloadable webinars in the field of health; education services, namely, conducting online and telephonic instruction and courses in the fields of health and medical issues

Pharmaceutical preparations in the form of foams for use in the treatment of sclerotherapy of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in the treatment of sclerotherapy of veins; pharmaceutical preparations in the form of foams or for use in preparing foams, for sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilization treatment or for treatment of varicose veins, or arterio-venous malformations

Chemicals for use in the manufacture of pharmaceuticals for the treatment of angiologic disorders, particularly varicose veins; chemicals for use in the production of injectable foams

Medical services for diagnosis in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical health assessment services, namely, medical diagnostic testing, in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical treatment services in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical after-care services, namely, medical care services rendered after medical treatment and surgeries in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; providing health care information by telephone

Cannula needles; medical tubing for sclerotherapy; medical tubing for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering sclerosing foams; surgical and medical apparatus for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; surgical or medical apparatus for administering and producing foams for use in sterilization treatment; surgical and medical apparatus for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; devices for assessing the physical characteristics of such foams; devices for intravenous administration of foam and devices for monitoring the position and effect of foam in the human body; medical diagnostic devices for use in all the above medical conditions

Scientific research services related to sclerotherapy of veins including provision of treatment in the fields of phlebology, proctology and angiology

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jul 19, 2016 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 19, 2016 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 22, 2015 GNFN
FINAL REFUSAL E-MAILED
Dec 22, 2015 GNFR
FINAL REFUSAL WRITTEN
Dec 22, 2015 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 24, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 23, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 23, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 26, 2015 GNRN
NON-FINAL ACTION E-MAILED
May 26, 2015 GNRT
NON-FINAL ACTION WRITTEN
May 26, 2015 CNRT
ASSIGNED TO EXAMINER
May 18, 2015 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Mar 5, 2015 AMPX
ASSIGNED TO LIE
Mar 4, 2015 ALIE
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 26, 2015 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 24, 2015 PARI
NEW APPLICATION ENTERED
Feb 14, 2015 NWAP